
United States · Medical devices startup
Woven Orthopedic Technologies, LLC is a medical device company focused on developing specialized orthopedic solutions to improve screw fixation in compromised bone scenarios.
Funding reportedLast round: Non equity assistance
Woven Orthopedic Technologies, LLC is a medical device company focused on developing specialized orthopedic solutions to improve screw fixation in compromised bone scenarios.
Founded in 2013 and headquartered in Manchester, Connecticut, the company aims to make neuromusculoskeletal treatments more efficient and accessible globally. Their flagship product, the Ogmend® Implant Enhancement System, is an implantable sleeve designed to enhance the screw-to-bone interface, particularly in patients with conditions like osteoporosis. This clinically proven and patented technology is compatible with existing screw fixation systems and is available in two sizes for various surgical applications. Woven Orthopedic Technologies targets orthopedic surgeons and global health systems, addressing a significant market of trauma and spine procedures performed annually on patients with compromised bone.
Funding, as reported
From the SEC filings it signed: 3 on the team.
On the board, as filediAnthony ViscogliosiFrank CammisaJ Douglas CraftJohn Moran
What they build
Known for
health carebone interface improvementfracture fixationbone ingrowthfixation augmentationhardware + softwaresurgical innovationlong bone fixationdistributionbone ingrowth promotionmanufacturingscrew fixation enhancementbone stabilitymedical equipment manufacturinginformation technology & servicesstress distribution
Built with from their website
Google Tag Managerparallax.jsSquarespace ECommerceViewport MetaDocSendPriority HintsGoogle Font APIMagento 2Microsoft ExchangeMicrosoft 365 Apps & Services
Mobile FriendlyMagento Open SourceOpen GraphSquarespaceGoogle AnalyticsMicrosoft Exchange OnlineHSTSMicrosoft 365
Add your raise, your deck and your story, and put Woven Orthopedic Technologies, LLC in front of investors. Or tell us what we have wrong.